Credit Suisse’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $212M | Sell |
|
|||||
|
2023
Q4 | $251M | Sell |
|
|||||
|
2023
Q3 | $261M | Buy |
|
|||||
|
2023
Q2 | $268M | Sell |
|
|||||
|
2023
Q1 | $289M | Buy |
|
|||||
|
2022
Q4 | $273M | Sell |
|
|||||
|
2022
Q3 | $212M | Sell |
|
|||||
|
2022
Q2 | $219M | Sell |
|
|||||
|
2022
Q1 | $242M | Buy |
|
|||||
|
2021
Q4 | $253M | Buy |
|
|||||
|
2021
Q3 | $239M | Sell |
|
|||||
|
2021
Q2 | $249M | Buy |
|
|||||
|
2021
Q1 | $228M | Sell |
|
|||||
|
2020
Q4 | $224M | Sell |
|
|||||
|
2020
Q3 | $262M | Sell |
|
|||||
|
2020
Q2 | $364M | Buy |
|
|||||
|
2020
Q1 | $260M | Sell |
|
|||||
|
2019
Q4 | $244M | Buy |
|
|||||
|
2019
Q3 | $201M | Buy |
|
|||||
|
2019
Q2 | $207M | Sell |
|
|||||
|
2019
Q1 | $201M | Sell |
|
|||||
|
2018
Q4 | $230M | Buy |
|
|||||
|
2018
Q3 | $261M | Buy |
|
|||||
|
2018
Q2 | $223M | Sell |
|
|||||
|
2018
Q1 | $304M | Sell |
|
|||||
|
2017
Q4 | $301M | Buy |
|
|||||
|
2017
Q3 | $332M | Sell |
|
|||||
|
2017
Q2 | $300M | Sell |
|
|||||
|
2017
Q1 | $386M | Sell |
|
|||||
|
2016
Q4 | $427M | Sell |
|
|||||
|
2016
Q3 | $548M | Buy |
|
|||||
|
2016
Q2 | $520M | Buy |
|
|||||
|
2016
Q1 | $546M | Buy |
|
|||||
|
2015
Q4 | $533M | Buy |
|
|||||
|
2015
Q3 | $487M | Sell |
|
|||||
|
2015
Q2 | $705M | Sell |
|
|||||
|
2015
Q1 | $674M | Sell |
|
|||||
|
2014
Q4 | $689M | Buy |
|
|||||
|
2014
Q3 | $693M | Buy |
|
|||||
|
2014
Q2 | $419M | Sell |
|
|||||
|
2014
Q1 | $361M | Sell |
|
|||||
|
2013
Q4 | $394M | Buy |
|
|||||
|
2013
Q3 | $297M | Sell |
|
|||||
|
2013
Q2 | $351M | Buy |
|